Skip to content

Peptide library / Brain & sleep / PE-22-28

Wellness and performanceBrain & sleep

PE-22-28

A short synthetic peptide studied in mice as a fast-acting antidepressant.

Body system
Brain & sleep
Status
Wellness and performance
Strongest evidence
Animals
Also known as
Spadin analog

Effects studied or claimed

What it is used or promoted for, and where each effect has actually been seen

  • Depression-like behavior in miceAnimals
  • Mood and focus, promotedLab

How it is thought to work

PE-22-28 is a shortened version of spadin and blocks the TREK-1 potassium channel, which in mice speeds up the response to antidepressant treatment.

What the evidence shows

Mouse studies reported antidepressant-like effects within days. There are no human trials.

Safety and unknowns

Human safety is unknown. Products sold online are not quality-controlled.

Regulatory status

Not approved. Sold as a research chemical.

Regulatory status changes quickly. This entry was last reviewed on 27 October 2026. Confirm current status with the FDA before relying on it.

More in Brain & sleep

General information, not medical advice. Do not buy or inject unregulated peptides.